Zobrazeno 1 - 10
of 242
pro vyhledávání: '"Roger Y Dodd"'
Publikováno v:
Emerging Infectious Diseases, Vol 29, Iss 7, Pp 1323-1329 (2023)
We evaluated antibodies to the nucleocapsid protein of SARS-CoV-2 in a large cohort of blood donors in the United States who were recently infected with the virus. Antibodies to the nucleocapsid protein of SARS-CoV-2 indicate previous infection but a
Externí odkaz:
https://doaj.org/article/7feb121b4be64d14b25cac1b56d71219
Publikováno v:
Transfusion. 63:764-773
Autor:
Roger Y, Dodd, Susan L, Stramer
Publikováno v:
Transfusion Clinique et Biologique. 30:35-38
Continuous improvement has led to a very high degree of microbial safety of transfusion. Four issues are likely to impact the future of this safety. There will be further advances in the efficacy and efficiency of donation testing and pathogen reduct
Autor:
Roger Y. Dodd, Susan L. Stramer
Publikováno v:
Transfusion Medicine Reviews. 37:7-9
Autor:
Roger Y. Dodd
Publikováno v:
Practical Transfusion Medicine
Autor:
Steven J. Drews, Roger Y. Dodd
Publikováno v:
Practical Transfusion Medicine. :206-220
Publikováno v:
Transfusion. 62:143-150
In 2019, the Food and Drug Administration revised the requirement for further testing of anti-HCV-reactive donations testing nucleic acid (NAT)-nonreactive via routine mini-pool (MP)-NAT. Individual donation (ID)-HCV NAT was required as a supplementa
Autor:
Laura Tonnetti, Roger Y Dodd, Donna D Burke, Paula Saá, Bryan R Spencer, Meng Xu, James M Haynes, Susan L Stramer
Publikováno v:
Open Forum Infectious Diseases. 10
Background Blood donors were tested for antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); resulting antibody levels were monitored over time. Methods Donors reactive to anti-SARS-CoV-2 spike protein (S1-total antibodies) par
Autor:
Susan L. Stramer, Paula Saá, Gregory A. Foster, Meng Xu, Roger Y. Dodd, Jaye P. Brodsky, Bryan R. Spencer
Publikováno v:
Transfusion Medicine Reviews
In the United States, many blood collection organizations initiated programs to test all blood donors for antibodies to SARS-CoV-2, as a measure to increase donations and to assist in the identification of potential donors of COVID-19 convalescent pl
Autor:
Transfusion-Transmissible Infections Monitoring System, Whitney R. Steele, Roger Y. Dodd, Rita Reik, Alan E. Williams, Edward P. Notari, Diane Nelson, Debra Kessler, Susan L. Stramer, Meng Xu, Brian Custer
Publikováno v:
Transfusion. 60:2327-2339
Background The Transfusion-Transmissible Infections Monitoring System (TTIMS) combines data from four US blood collection organizations including approximately 60% of all donations to monitor demographic and temporal trends in infectious disease mark